3421 字
17 分钟
设计药物
Waiting for api.github.com...
提示移动端打开桌面版网站才能更好查看
备注添加了 wiki 链接,中划线表示已被列管
简介
设计药物是与管制物质的结构或功能的类似物,旨在模仿母体药物的药理作用,同时规避法律监管等。但还有许多其他的新型精神活性物质 ,可被视为设计药物的一部分。设计药物亦可称为设计师药物,狡诈家药物等。
文件下载
2C-x
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 1222814-77-8 | 2-[4-(2-fluoroethyl)-2,5-dimethoxyphenyl]ethanamine | 2C-EF | COC1=CC(CCF)=C(OC)C=C1CCN |
2 | 2888537-57-1 | 2-(4-ethenyl-2,5-dimethoxyphenyl)ethanamine | 2C-V | C=CC1=C(OC)C=C(CCN)C(OC)=C1 |
3 | 752982-24-4 | 2-(4-ethynyl-2,5-dimethoxyphenyl)ethanamine | 2C-YN | COC1=CC(=C(C=C1CCN)OC)C#C |
4 | 2756686-02-7 | 2-(2,5-dimethoxy-4-prop-2-enylphenyl)ethanamine | 2C-AL | C=CCC1=C(OC)C=C(CCN)C(OC)=C1 |
5 | 2888537-46-8 | 2-(4-cyclopropyl-2,5-dimethoxyphenyl)ethanamine | 2C-CP | COC1=CC(C2CC2)=C(OC)C=C1CCN |
6 | 1498978-47-4 | 2-[2,5-Dimethoxy-4-(propan-2-yl)phenyl]ethan-1-amine | 2C-iP | COC1=CC(C(C)C)=C(OC)C=C1CCN |
7 | 952006-95-0 | 2-[4-(Cyclopropylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine | 2C-T-15 | COC1=CC(SC2CC2)=C(OC)C=C1CCN |
8 | 15394-83-9 | 2-(2,4,5-Trimethoxyphenyl)ethan-1-amine | 2C-O | COC1=CC(OC)=C(OC)C=C1CCN |
9 | 952006-65-4 | 2-{2,5-Dimethoxy-4-[(propan-2-yl)oxy]phenyl}ethan-1-amine | 2C-O-4 | COC1=CC(OC(C)C)=C(OC)C=C1CCN |
10 | 733720-95-1 | 2-(4-Bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-8-yl)ethanamine | 2C-B-FLY | NCCC1=C2OCCC2=C(Br)C2=C1CCO2 |
DOx
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 125903-69-7 | 1-(4-Fluoro-2,5-dimethoxyphenyl)propan-2-amine | DOF | COC1=C(F)C=C(OC)C(CC(C)N)=C1 |
2 | 64584-34-5 | 4-Iodo-2,5-dimethoxyphenylisopropylamine | DOI | COC1=C(I)C=C(OC)C(CC(C)N)=C1 |
3 | 42456-77-9 | 1-(4-tert-butyl-2,5-dimethoxyphenyl)propan-2-amine | DOTB | COC1=CC(C(C)(C)C)=C(OC)C=C1CC(C)N |
4 | 63779-89-5 | 1-(4-butyl-2,5-dimethoxyphenyl)propan-2-amine | DOBU | CCCCC1=C(OC)C=C(CC(C)N)C(OC)=C1 |
5 | 125903-73-3 | 1-(4-benzyl-2,5-dimethoxyphenyl)propan-2-amine | DOBN | COC1=C(CC2=CC=CC=C2)C=C(OC)C(CC(C)N)=C1 |
6 | 121649-01-2 | 1-[4-(2-fluoroethyl)-2,5-dimethoxyphenyl]propan-2-amine | DOEF | COC1=C(CCF)C=C(OC)C(CC(C)N)=C1 |
7 | 22004-32-6 | 1-(4-Ethyl-2,5-dimethoxyphenyl)propan-2-amine | DOET | CCC1=C(OC)C=C(CC(C)N)C(OC)=C1 |
8 | 63779-88-4 | 1-(2,5-Dimethoxy-4-propylphenyl)propan-2-amine | DOPR | CCCC1=CC(=C(C=C1OC)CC(C)N)OC |
9 | 67460-68-8 | 1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine | DON | CC(CC1=CC(=C(C=C1OC)[N+](=O)[O-])OC)N |
10 | 61638-07-1 | 1-[2,5-dimethoxy-4-(methylsulfanyl)phenyl]propan-2-amine | DOT | CC(CC1=CC(=C(C=C1OC)SC)OC)N |
11 | 89556-64-9 | 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]propan-2-amine | DOIB | CC(C)CC1=CC(=C(C=C1OC)CC(C)N)OC |
12 | 42306-96-7 | 1-[2,5-Dimethoxy-(propan-2-yl)phenyl]propan-2-amine | DOIP | CC(C)C1=C(C=C(C(=C1)OC)CC(C)N)OC |
13 | 1083-09-6 | 1-(2,4,5-trimethoxyphenyl)propan-2-amine | DOMeO(TMA-2) | CC(CC1=CC(=C(C=C1OC)OC)OC)N |
14 | 16128-88-4 | 1-[(4-ethoxy-2,5-dimethoxy)phenyl]propan-2-amine | DOEtO(MEM) | CCOC1=C(C=C(C(=C1)OC)CC(C)N)OC |
15 | 89556-71-8 | 1-(4-butan-2-yl-2,5-dimethoxyphenyl)propan-2-amine | DOSB | CCC(C)C1=C(C=C(C(=C1)OC)CC(C)N)OC |
16 | 219986-94-4 | 1-(4-bromofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine | DOB-DFLY | CC(CC1=C2C=COC2=C(C3=C1OC=C3)Br)N |
单胺杂项
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 64778-72-9 | 2-{3,5-Dimethoxy-4-[(propan-2-yl)oxy]phenyl}ethan-1-amine | Isoproscaline | COC1=CC(CCN)=CC(OC)=C1OC(C)C |
2 | 2176-16-1 | 2-(3,5-dimethoxy-4-phenylmethoxyphenyl)ethanamine | Benzscaline | COC1=C(OCC2=CC=CC=C2)C(OC)=CC(CCN)=C1 |
3 | 52842-59-8 | 1-(2,5-dimethoxy-4-methylphenyl)butan-2-amine | 4C-D | CCC(N)CC1=CC(OC)=C(C)C=C1OC |
4 | 147947-26-0 | 1-[4-(benzyloxy)-3,5-dimethoxyphenyl]propan-2-amine | 3C-BZ | COC1=C(OCC2=CC=CC=C2)C(OC)=CC(CC(C)N)=C1 |
xAI
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 132367-76-1 | 5-Iodo-2-aminoindane | 5-IAI | NC1CC2=C(C=C(I)C=C2)C1 |
2 | 2760617-90-9 | 5,6-benzofuranyl-2-aminoindane | BFAI | NC1CC2=C(C=C3OCCC3=C2)C1 |
3 | 205652-94-4 | N-Ethyl-5-trifluoromethyl-2-aminoindane | ETAI | CCNC1CC2=CC=C(C(F)(F)F)C=C2C1 |
4 | 136468-19-4 | 5-Methoxy-6-methyl-2-aminoindane | MMAI | COC1=CC2=C(C=C1C)CC(N)C2 |
5 | 73305-09-6 | 5-Methoxy-2-aminoindane | 5-MeO-AI | COC1=CC2=C(C=C1)CC(N)C2 |
xLSx
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | (6aR,9R)-N,N-Diethyl-7-methyl-4-Benzoyl- 4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide |
1Bz-LSD | CCN(CC)C(=O)[C@@H]1C=C2C3=CC=CC4=C3C(=CN4C(=O)C3=CC=CC=C3)C[C@]2N(C)C1 |
|
2 | (6aR,9R)-4-(Cyclopropanecarbonyl)-N,N-diethyl-7-prop-2-enyl- 6,6a,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide |
1cP-AL-LAD | C=CCN1C[C@](C(=O)N(CC)CC)C=C2C3=CC=CC4=C3C(=CN4C(=O)C3CC3)C[C@]21 |
取代色胺
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 1-t-Butyloxycarbonyl-N,N-Dimethyltryptamine | NB-DMT | CN(C)CCC1=CN(C(=O)OC(C)(C)C)C2=CC=CC=C12 |
|
2 | tert-butyl 3-(2-(diallylamino)ethyl)-5-methoxy-1H-indole-1-carboxylate | NB-5-MeO-DALT | C=CCN(CC=C)CCC1=CN(C(=O)OC(C)(C)C)C2=CC=C(OC)C=C12 |
|
3 | tert-butyl 3-(2-(isopropyl(methyl)amino)ethyl)-5-methoxy-1H-indole-1-carboxylate | NB-5-MeO-MiPT | COC1=CC=C2C(=C1)C(CCN(C)C(C)C)=CN2C(=O)OC(C)(C)C |
|
4 | 61-52-9 | N-[2-(1H-indol-3-yl)ethyl]-N-propylpropan-1-amine | DPT | CCCN(CCC)CCC1=CNC2=CC=CC=C12 |
5 | 850032-72-3 | N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-1-amine | MPT | CCCN(C)CCC1=CNC2=CC=CC=C12 |
6 | 5599-69-9 | N-ethyl-2-(1H-indol-3-yl)-N-methylethanamine | MET | CCN(C)CCC1=CNC2=CC=CC=C12 |
7 | 850032-68-7 | N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-1-amine | EPT | CCCN(CC)CCC1=CNC2=CC=CC=C12 |
8 | 1218-40-2 | N,N-diethyl-2-(5-methoxy-1H-indol-3-yl)ethanamine | 5-MeO-DET | CCN(CC)CCC1=CNC2=CC=C(OC)C=C12 |
9 | 1445751-40-5 | [3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-yl]acetate | 4-AcO-MET | CCN(C)CCC1=CNC2=CC=CC(OC(C)=O)=C12 |
10 | 1135424-15-5 | [3-[2-(diethylamino)ethyl]-1H-indol-4-yl]acetate | 4-AcO-DET | CCN(CC)CCC1=CNC2=CC=CC(OC(C)=O)=C12 |
11 | 1024612-25-6 | [3-[2-[methyl(propan-2-yl)amino]ethyl]-1H-indol-4-yl]acetate | 4-AcO-MiPT | CC(=O)OC1=C2C(CCN(C)C(C)C)=CNC2=CC=C1 |
12 | 1024612-25-6 | [3-[2-[ethyl(propan-2-yl)amino]ethyl]-1H-indol-4-yl]acetate | 4-AcO-EiPT | CCN(CCC1=CNC2=CC=CC(OC(C)=O)=C12)C(C)C |
13 | 936015-60-0 | [3-[2-[di(propan-2-yl)amino]ethyl]-1H-indol-4-yl]acetate | 4-AcO-DiPT | CC(=O)OC1=C2C(CCN(C(C)C)C(C)C)=CNC2=CC=C1 |
14 | 1445751-75-6 | [3-[2-(dipropylamino)ethyl]-1H-indol-4-yl]acetate | 4-AcO-DPT | CCCN(CCC)CCC1=CNC2=CC=CC(OC(C)=O)=C12 |
15 | 77872-41-4 | 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol | 4-OH-MET | CCN(C)CCC1=CNC2=CC=CC(O)=C12 |
16 | 22204-89-3 | 3-[2-(diethylamino)ethyl]-1H-indol-4-o | 4-HO-DET | CCN(CC)CCC1=CNC2=CC=CC(O)=C12 |
17 | 132328-45-1 | 3-[2-[di(propan-2-yl)amino]ethyl]-1H-indol-4-ol | 4-HO-DiPT | CC(C)N(CCC1=CNC2=CC=CC(O)=C12)C(C)C |
18 | 63065-88-3 | 3-[2-(diethylamino)ethyl]-1H-indol-4-o | 4-HO-DPT | CCCN(CCC)CCC1=CNC2=CC=CC(O)=C12 |
19 | 2595431-59-5 | 3-{2-[ethyl(propyl)amino]ethyl}-1H-indol-4-ol | 4-HO-EPT | CCCN(CC)CCC1=CNC2=CC=CC(O)=C12 |
20 | 763035-03-6 | 3-[2-[methyl(propyl)amino]ethyl]-1H-indol-4-ol | 4-HO-MPT | CCCN(C)CCC1=CNC2=C1C(=CC=C2)O |
21 | 2173386-70-2 | 3-[2-[bis(prop-2-enyl)amino]ethyl]-1H-indol-4-ol | 4-HO-DALT | C=CCN(CCC1=CNC2=C1C(=CC=C2)O)CC=C |
22 | 143321-54-4 | 3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole | MPMI | CN1CCCC1CC1=CNC2=CC=CC=C12 |
23 | 250672-65-2 | (R)-3-(N-methylpyrrolidin-2-ylmethyl)-4-hydoxyindole | 4-HO-MPMI | CN1CCC[C@@H]1CC1=CNC2=CC=CC(O)=C12 |
24 | 143321-57-7 | 5-Methoxy-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole | 5-MeO-MPMI | COC1=CC=C2NC=C(C[C@H]3CCCN3C)C2=C1 |
类芬太尼
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 63916-05-2 | N-phenyl-N-[1-(4-phenylpiperidin-1-yl)propan-2-yl]propanamide | CCC(=O)N(C1=CC=CC=C1)C(C)CN1CCC(C2=CC=CC=C2)CC1 |
|
2 | N-{1-[methyl(2-phenylethyl)amino]propan-2-yl}-N-phenylpropanamide | CCC(=O)N(C1=CC=CC=C1)C(C)CN(C)CCC1=CC=CC=C1 |
||
3 | 76754-18-2 | N-phenyl-N-[(1R,5S)-8-(2-phenylethyl)-8-azabicyclo[3.2.1]octan-3-yl]propanamide | CCC(=O)N(C1C[C@H]2CC[C@@H](C1)N2CCC3=CC=CC=C3)C4=CC=CC=C4 |
|
4 | 344235-54-7 | N-phenyl-N-[1-(2-phenylethyl)azepan-4-yl]propanamide | CCC(=O)N(C1CCCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3 |
苯并咪唑
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | CCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(C)C)C=CC(=C3)[N+](=O)[O-] |
|||
2 | CCC(C)OC1=CC=C(CC2=NC3=C(C=CC([N+](=O)[O-])=C3)N2CCN(CC)CC)C=C1 |
Utopioid
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 67198-13-4 | 2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide | U-50488 | CN(C(=O)CC1=CC=C(Cl)C(Cl)=C1)[C@@H]1CCCC[C@H]1N1CCCC1 |
2 | 96744-75-1 | N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide | U-69593 | CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC=CC=C4 |
3 | 87151-85-7 | 2-(3,4-Dichlorophenyl)-N-methyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl] acetamide | U-62066 | CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl |
4 | 124378-77-4 | 2-(1-Benzofuran-4-yl)-N-methyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl]acetamide | Enadoline(Cl-977) | CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=C5C=COC5=CC=C4 |
5 | 119878-31-8 | 3,4-Dibromo-N-methyl-N-[(5S,6R)-1-methyl-1-azaspiro[4.5]decan-6-yl]benzamide | U-77891 | CN1CCC[C@]12CCCC[C@H]2N(C)C(=O)C3=CC(=C(C=C3)Br)Br |
6 | 492451-07-7 | 2-(3,4-dichlorophenyl)-N-[(2S)-1-(2,5-dihydropyrrol-1-yl)-3-methylbutan-2-yl]-N-methylacetamide | LPK-26 | CC(C)[C@@H](CN1CC=CC1)N(C)C(=O)CC2=CC(=C(C=C2)Cl)Cl |
7 | 2370977-17-4 | 2-(2,4-dichlorophenyl)-N-[(1S,2S)-2-(dimethylamino)cyclohexyl]-N-methylacetamide | U-48800 | CN(C)[C@H]1CCCC[C@@H]1N(C)C(=O)CC2=C(C=C(C=C2)Cl)Cl |
8 | 2488874-96-8 | N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methyl-1,3-benzodioxole-5-carboxamide | 3,4-MDO-U-47700 | CN(C)[C@@H]1CCCC[C@H]1N(C)C(=O)C1=CC2=C(C=C1)OCO2 |
9 | 1441000-45-8 | 4-Butoxy-N-([4-(dimethylamino)oxan-4-yl]methyl)-3,5-dimethoxybenzamide | Opiranserin(VVZ-149) | CCCCOC1=C(OC)C=C(C(=O)NCC2(N(C)C)CCOCC2)C=C1OC |
新型阿片
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 1401029-50-2 | N-[(5-fluoropyridin-3-yl)methyl]-2-[(9R)-9-pyridin-2-yl- 6-oxaspiro[4.5]decan-9-yl]ethanamine |
TRV734 | FC1=CC(CNCC[C@]2(C3=NC=CC=C3)CCOC3(CCCC3)C2)=CN=C1 |
2 | 2095345-71-2 | (1'S)-N-[2-[(9R)-9-pyridin-2-yl-6-oxaspiro[4.5]decan-9-yl]ethyl] spiro[1,3-dithiolane-2,4'-2,3-dihydro-1H-naphthalene]-1'-amine |
SHR9352 | C1=CN=C([C@]2(CCN[C@H]3CCC4(SCCS4)C4=CC=CC=C43)CCOC3(CCCC3)C2)C=C1 |
3 | (1R,2R)-2-methoxy-N-[2-[(9R)-9-pyridin-2-yl-6-oxaspiro[4.5]decan-9-yl] ethyl]-2,3-dihydro-1H-inden-1-amine |
CO[C@H]1CC2=CC=CC=C2[C@H]1NCC[C@]1(C2=NC=CC=C2)CCOC2(CCCC2)C1 |
||
4 | [(3-chlorophenyl)methyl]({2-[(5S,9R)-9-(5-fluoropyridin-2-yl)- 2,6-dioxaspiro[4.5]decan-9-yl]ethyl})amine |
LPM3480392 | FC1=CN=C([C@]2(CCNCC3=CC=CC(Cl)=C3)CCO[C@]3(CCOC3)C2)C=C1 |
吗啡喃
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 13965-63-4 | (2R)-2-((4R,7S,7aR,12bS,14R)-7,9-dimethoxy-3-methyl-1,2,3,4,7,7a-hexahydro- 7,4a-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-14-yl)-4-phenylbutan-2-ol |
7-PET | COC1=C2O[C@H]3[C@]45CCN(C)[C@H](CC(=C24)C=C1)[C@]51C=C[C@]3(OC)[C@H]([C@](C)(O)CCC2=CC=CC=C2)C1 |
2 | 1374406-56-0 | 7α-[(R)-1-hydroxy-1-methyl-3-(thiophen-3-yl)-propyl]-6,14-endo-ethanotetrahydrooripavine | TH-030418 | CO[C@]12CC[C@]3(C[C@H]1[C@](C)(O)CCC1=CC=CS1)[C@H]1CC4=CC=C(O)C5=C4[C@]3(CCN1C)[C@H]2O5 |
3 | 131575-03-6 | 3-Hydroxy-14-methoxy-5,17-dimethyl-7,8-dihydro-4,5α-epoxy-morphinan-6-one | 14-Methoxymetopon | CO[C@]12CCC(=O)[C@]3(C)OC4=C5C(=CC=C4O)C[C@H]1N(C)CC[C@]523 |
4 | 3-Hydroxy-14-(3-phenylpropoxy)-5-methyl-7,8-dihydro-4,5α-epoxy-17-methylmorphinan-6-one | PPOM | CN1CC[C@]23C4=C5O[C@]2(C)C(=O)CC[C@]3(OCCCC2=CC=CC=C2)C1CCC4=CC=C5O |
|
5 | 751-01-9 | 7,8-didehydro-4,5α-epoxy-14-cinnamoyl-3-methoxy-17-methylmorphinan-6-one | 14-Cinnamoyloxycodeinone | CN1CC[C@]23[C@@H]4C(=O)C=C[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)OC(=O)/C=C/C6=CC=CC=C6 |
6 | 4778-96-5 | 3,6,14-trihydroxy-4,5α-epoxy-17-(2-phenylethyl)morphinan | RAM-378 | OC1=CC=C2C[C@H]3N(CCC4=CC=CC=C4)CC[C@]45C2=C1O[C@H]4[C@H](O)CC[C@]35O |
7 | 722450-07-9 | 3-hydroxy-4,5α-epoxy-17-(2-phenylethyl)morphinan | N-Phenethylnordesomorphine | OC1=CC=C2C[C@H]3[C@H]4CCC[C@H]5OC1=C2[C@]54CCN3CCC1=CC=CC=C1 |
8 | 27767-85-7 | 17-(2-(Furan-2-yl)ethyl)-3-hydroxymorphinan | Ro4-1539 | OC1=CC=C2C[C@H]3[C@H]4CCCC[C@]4(CCN3CCC3=CC=CO3)C2=C1 |
9 | 62509-10-8 | (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-([(R)-tetrahydrofuran-2-yl]methyl)- 2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)one |
MR-2096 | O=C1CC[C@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@]2(CCN3C[C@H]2CCCO2)[C@H]1O5 |
阿片杂项
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 3222-88-6 | 8-[1-(4-chlorophenyl)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | R6890 | CC(C1=CC=C(Cl)C=C1)N1CCC2(CC1)C(=O)NCN2C1=CC=CC=C1 |
2 | 863513-91-1 | (1r,4r)-6'-Fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano<[3,4-b]indol]-4-amine | GRT-6005 | CN(C)[C@]1(C2=CC=CC=C2)CC[C@]2(CC1)OCCC1C3=CC(F)=CC=C3NC12 |
3 | 1997387-43-5 | 1-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea | PZM21 | C[C@H](CC1=CSC=C1)NC(=O)NC[C@H](CC1=CC=C(O)C=C1)N(C)C |
4 | 127093-63-4 | (5S)-5-[(1S)-2-[bis[(2R)-butan-2-yl]amino]-1-hydroxyethyl]-1-(2-chlorobenzyl)pyrrolidin-2-one | Z4349 | CC[C@H](C)N(C[C@H](O)[C@H]1CCC(=O)N1CC1=C(Cl)C=CC=C1)[C@H](C)CC |
5 | 1849034-34-9 | N-[[1-[[(5S)-5-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl]methyl]piperidin-2-yl]methyl]-N-phenylpropanamide | CCC(=O)N(CC1CCCCN1CC1=CC2=C(C=C1)[C@H](O)CCC2)C1=CC=CC=C1 |
|
6 | 54160-31-5 | 1-[4,4-Di(thiophen-2-yl)but-3-en-2-yl]piperidine | Piperidinohton | CC(C=C(C1=CC=CS1)C1=CC=CS1)N1CCCCC1 |
7 | 2244737-98-0 | 3-{1-[1-(4-bromophenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-one | Brorphine | CC(C1=CC=C(Br)C=C1)N1CCC(N2C(=O)NC3=CC=CC=C32)CC1 |
8 | 616898-54-5 | trans-4-(p-Bromophenyl)-4-(dimethylamino)-1-(2-(thiophen-2-yl)ethyl)cyclohexanol | C-8813 | CN(C)[C@]1(C2=CC=C(Br)C=C2)CC[C@](O)(CCC2=CC=CS2)CC1 |
AP
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 140448-34-0 | 1-(3-((E)-3-Phenylprop-2-enyl)-3,8-diazabicyclo[3.2.1]octan-8-yl)propan-1-one | Azaprocin | CCC(=O)N1C2CCC1CN(C2)C/C=C/C3=CC=CC=C3 |
2 | 140924-11-4 | 1-[(2R,6S)-2,6-dimethyl-4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]propan-1-one | AP-238 | CCC(=O)N1[C@@H](CN(C[C@@H]1C)C/C=C/C2=CC=CC=C2)C |
类哌替啶
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 469-80-7 | ethyl 4-phenyl-1-(2-phenylethyl)piperidine-4-carboxylate | Pheneridine | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCC2=CC=CC=C2)CC1 |
2 | 258500-87-7 | ethyl 4-(4-fluorophenyl)-1-methylpiperidine-4-carboxylate | 4-Fluoropethidine | CCOC(=O)C1(C2=CC=C(F)C=C2)CCN(C)CC1 |
3 | 878895-45-5 | [3-(4-acetyl-1-methylpiperidin-4-yl)phenyl]acetate | O-AMKD | CC(=O)OC1=CC=CC(C2(C(C)=O)CCN(C)CC2)=C1 |
4 | 64058-44-2 | 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone | Methylketobemidone | CC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1 |
5 | 428-37-5 | 3-(1-methyl-3-propyl-pyrrolidin-3-yl)phenol | Profadol (CI-572) | CCC[C@@]1(C2=CC(O)=CC=C2)CCN(C)C1 |
类曲马多
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 65619-06-9 | 4-(Dimethylamino)-4-(4-methylphenyl)cyclohexan-1-one | CC1=CC=C(C2(N(C)C)CCC(=O)CC2)C=C1 |
|
2 | 433265-65-7 | 3-[(1R,2R)-2-dimethylaminomethylcyclohexyl]phenol | Faxeladol(GRTA-9906) | CN(C)C[C@H]1CCCC[C@H]1C1=CC=CC(O)=C1 |
3 | 63269-31-8 | 3-{(R)-Dimethylamino-[(1R,2R)-2-hydroxycyclohexyl]}methyl]phenol | Ciramadol(WY-15705) | CN(C)[C@H](C1=CC=CC(O)=C1)[C@H]1CCCC[C@H]1O |
类美沙酮
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 114538-73-7 | 4-ethylsulfonyl-N,N-dimethyl-4,4-diphenylbutan-2-amine | IC-26 | CCS(=O)(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
2 | 1767-88-0 | 4-(Morpholin-4-yl)-2,2-diphenyl-1-(pyrrolidin-1-yl)butan-1-one | Desmethylmoramide | O=C(N1CCCC1)C(CCN1CCOCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
3 | 60996-94-3 | 4,4-diphenyl-6-(1-pyrrolidinyl)-heptan-3-one | Dipyanone | CCC(=O)C(CC(C)N1CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
4 | 66194-36-3 | 4,4-diphenyl-6-spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine]-1'-ylhexan-3-one | R-4066 | CCC(=O)C(CCN1CCC2(CCCC3=CC=CC=C32)CC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
合成大麻素
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 152674-96-9 | (6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-6,6,9-trimethyl- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
AM-087 | CC1=CC[C@@H]2[C@@H](C1)C1=C(C=C(C(C)(C)CCCCBr)C=C1O)OC2(C)C |
2 | 212835-02-4 | (6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
AM-411 | CC1=CC[C@@H]2[C@@H](C1)C1=C(C=C(C34CC5CC(CC(C5)C3)C4)C=C1O)OC2(C)C |
3 | 1256842-49-5 | (6aR,9R,10aR)-3-(1-hexylcyclobut-1-yl)-6a,7,8,9,10,10a-hexahydro- 6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 diol |
AM-2389 | CCCCCCC1(C2=CC3=C(C(O)=C2)[C@@H]2C[C@H](O)CC[C@H]2C(C)(C)O3)CCC1 |
4 | 129658-01-1 | (6aR,9R,10aR)-6,6-dimethyl-3-(5-phenylpentan-2-yloxy)- 6a,7,8,9,10,10a-hexahydrobenzo[c]chromene-1,9-diol |
CP-42096 | CC(CCCC1=CC=CC=C1)OC1=CC2=C(C(O)=C1)[C@@H]1C[C@H](O)CC[C@H]1C(C)(C)O2 |
5 | 140835-18-3 | (6aR,8S,9S,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)- 8,9-ditritio-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-1-ol |
HU-243 | CCCCCCC(C)(C)C1=CC2=C(C(O)=C1)[C@@H]1C[C@H](CO)CC[C@H]1C(C)(C)O2 |
6 | 181139-62-8 | (6aR,9R,10aR)-3-[(E)-hept-1-enyl]-9-(hydroxymethyl)- 6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol |
AM-905 | CCCCC/C=C/C1=CC(=C2[C@@H]3C[C@@H](CC[C@H]3C(OC2=C1)(C)C)CO)O |
7 | 587023-54-9 | (6S,6aR,9R,10aR)-9-(hydroxymethyl)-6-[(E)-3-hydroxyprop-1-enyl]-6-methyl- 3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol |
AM-4043 | CCCCCCC(C)(C)C1=CC(=C2[C@@H]3C[C@@H](CC[C@H]3[C@](OC2=C1)(C)/C=C/CO)CO)O |
8 | 303113-08-8 | (6S,6aR,9R,10aR)-9-(Hydroxymethyl)-6-(3-hydroxyprop-1-ynyl)-6-methyl- 3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol |
AM-938 | CCCCCCC(C)(C)C1=CC(=C2[C@@H]3C[C@@H](CC[C@H]3[C@](OC2=C1)(C)C#CCO)CO)O |
9 | 131543-22-1 | (11R)-2-Methyl-11-[(morpholin-4-yl)methyl]-3-(naphthalene-1-carbonyl)- 9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraene |
WIN-55212-2 | CC1=C(C(=O)C2=C3C=CC=CC3=CC=C2)C2=C3C(=CC=C2)OC[C@@H](CN2CCOCC2)N13 |
10 | 824960-02-3 | (4-propylnaphthalen-1-y)l-(1-pentylindol-3-yl)methanone | JWH-182 | CCCCCN1C=C(C(=O)C2=CC=C(CCC)C3=CC=CC=C23)C2=CC=CC=C21 |
11 | 1366067-59-5 | (4-bromonaphthalen-1-yl)-(1-pentylindol-3-yl)methanone | JWH-387 | CCCCCN1C=C(C(=O)C2=CC=C(Br)C3=CC=CC=C23)C2=C1C=CC=C2 |
12 | 824960-03-4 | (2-methyl-1-pentylindol-3-yl)-(4-propylnaphthalen-1-yl)methanone | JWH-181 | CCCCCN1C(C)=C(C(=O)C2=CC=C(CCC)C3=CC=CC=C23)C2=CC=CC=C21 |
13 | 316189-74-9 | (4-methoxynaphthalen-1-yl)-(2-methyl-1-pentylindol-3-yl)methanone | JWH-098 | CCCCCN1C(C)=C(C(=O)C2=CC=C(OC)C3=CC=CC=C23)C2=C1C=CC=C2 |
14 | 71048-87-8 | [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy- 5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate |
Levonantradol (CP-50556-1) |
CC(=O)OC1=CC(O[C@H](C)CCCC2=CC=CC=C2)=CC2=C1[C@@H]1C[C@H](O)CC[C@H]1[C@H](C)N2 |
15 | 79678-32-3 | (2S,4S,4aS,6R,8aR)-6-(Hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]- 1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-o |
CP-55244 | CCCCCCC(C)(C)C1=CC=C(C2C[C@H](O)C[C@@H]3CC[C@H](CO)C[C@@H]23)C=C1 |
xPCx
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 23036-19-3 | 1-(1-Phenylcyclopentyl)piperidine | C1=CC=C(C2(N3CCCCC3)CCCC2)C=C1 |
|
2 | 1622348-63-3 | 1-[1-(3-methylphenyl)cyclohexyl]pyrrolidine | 3-Me-PCPy | CC1=CC(C2(N3CCCC3)CCCCC2)=CC=C1 |
3 | 2201-30-1 | 1-[1-(3-methylphenyl)cyclohexyl]piperidine | 3-Me-PCP | CC1=CC(C2(N3CCCCC3)CCCCC2)=CC=C1 |
4 | 89156-99-0 | 1-[1-(3-fluorophenyl)cyclohexyl]piperidine | 3-F-PCP | FC1=CC(C2(N3CCCCC3)CCCCC2)=CC=C1 |
5 | 2201-32-3 | 1-[1-(3-chlorophenyl)cyclohexyl]piperidine | 3-Cl-PCP | ClC1=CC(C2(N3CCCCC3)CCCCC2)=CC=C1 |
6 | 3034185-93-5 | 1-[1-(1,3-benzodioxol-5-yl)cyclohexyl]piperidine | MDPCP | C1=C(C2(N3CCCCC3)CCCCC2)C=C2OCOC2=C1 |
7 | 65620-13-5 | 4-phenyl-4-piperidin-1-ylcyclohexan-1-one | 4-Keto-PCP | O=C1CCC(C2=CC=CC=C2)(N2CCCCC2)CC1 |
8 | 2201-40-3 | 4-(1-Phenylcyclohexyl)morpholine | PCMO | C1CCC(CC1)(C2=CC=CC=C2)N3CCOCC3 |
9 | 138873-80-0 | 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine | 3-MeO-PCMO | COC1=CC=CC(=C1)C2(CCCCC2)CN3CCOCC3 |
10 | 2201-64-1 | N-ethyl-1-(3-methylphenyl)cyclohexan-1-amine | 3-Me-PCE | CCNC1(CCCCC1)C2=CC=CC(=C2)C |
11 | 1364933-80-1 | N-Ethyl-1-(3-methoxyphenyl)cyclohexanamine | 3-MeO-PCE | CCNC1(C2=CC(OC)=CC=C2)CCCCC1 |
12 | 18949-81-0 | 1-phenyl-N-propylcyclohexanamine | PCPr | CCCNC1(C2=CC=CC=C2)CCCCC1 |
类氯胺酮
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 1782148-51-9 | 2-(3-Methoxyphenyl)-2-(methylamino)cyclohexanone | MXM | CNC1(C2=CC=CC(OC)=C2)CCCCC1=O |
2 | 2504100-71-2 | 2-(3-Methoxyphenyl)-2-(propylamino)cyclohexanone | MXPr | CCCNC1(C2=CC=CC(OC)=C2)CCCCC1=O |
3 | 7063-51-6 | 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexanone | Methoxyketamine | CNC1(C2=CC=CC=C2OC)CCCCC1=O |
4 | 2657761-23-2 | 2-(3-Fluorophenyl)-2-methylamino-cyclohexanone | 3-FDCK(FXM) | CNC1(C2=CC=CC(F)=C2)CCCCC1=O |
5 | 1782149-73-8 | 2-(methylamino)-2-[2-(trifluoromethyl)phenyl]cyclohexan-1-one | 2-TFMDCK | CNC1(C2=CC=CC=C2C(F)(F)F)CCCCC1=O |
6 | 2666932-55-2 | 2-(isopropylamino)-2-(3-methoxyphenyl)cyclohexan-1-one | MXiPr | COC1=CC(C2(NC(C)C)CCCCC2=O)=CC=C1 |
7 | 2-(2-chlorophenyl)-2-[(propan-2-yl)amino]cyclohexan-1-one | o-CliPr | CC(C)NC1(C2=CC=CC=C2Cl)CCCCC1=O |
|
8 | 1218-40-2 | 2-(2-bromophenyl)-2-(ethylamino)cyclohexan-1-one | 2-Oxo-2BrPCE | CCNC1(C2=C(Br)C=CC=C2)CCCCC1=O |
9 | 1450615-41-4 | Methyl 4-{[1-(2-chlorophenyl)-2-oxocyclohexyl]amino}pentanoate | SN-35210 | COC(=O)CCCCNC1(C2=C(Cl)C=CC=C2)CCCCC1=O |
10 | 14176-49-9 | 2-Ethylamino-2-(2-thienyl)cyclohexanone | Tiletamine | CCNC1(C2=CC=CS2)CCCCC1=O |
NMDA 拮抗剂
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 147085-68-5 | (4aR,9aS)-N-methyl-1,2,3,4,9,9a-hexahydrofluoren-4a-amine | PD-137889 | CN[C@]12CCCC[C@H]1CC1=CC=CC=C12 |
2 | 14326-31-9 | 3-amino-2-methyl-1,1-di(phenyl)propan-1-ol | 2-MDP | CC(CN)C(O)(C1=CC=CC=C1)C1=CC=CC=C1 |
3 | 77086-21-6 | (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine | Dizocilpine | C[C@]1(C2=C(C[C@H]3N1)C=CC=C2)C4=C3C=CC=C4 |
类利非他明
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | [1-(2-methoxyphenyl)-2-phenylethyl]dimethylamine | COC1=CC=CC=C1C(CC1=CC=CC=C1)N(C)C |
||
2 | 2149042-90-8 | 1-(1-(2-Fluorophenyl)-2-phenylethyl)pyrrolidine | Fluorolintane(2-F-DPPy) | FC1=CC=CC=C1C(CC1=CC=CC=C1)N1CCCC1 |
3 | 1,2-diphenyl-N-(2-phenylethyl)ethanamine | EPPE | C1=CC=C(CCNC(CC2=CC=CC=C2)C2=CC=CC=C2)C=C1 |
|
4 | 60951-19-1 | N-Ethyl-1,2-diphenylethylamine | Ephenidine(NEDPA,EPE) | CCNC(CC1=CC=CC=C1)C1=CC=CC=C1 |
5 | 64857-61-0 | N,N-diethyl-1,2-diphenylethanamine | CCN(CC)C(CC1=CC=CC=C1)C1=CC=CC=C1 |
|
6 | 1350821-28-1 | 2-(1,3-benzodioxol-5-yl)-N-methyl-1-phenylethanamine | UWA-001 | CNC(CC1=CC2=C(C=C1)OCO2)C3=CC=CC=C3 |
7 | 61311-01-1 | 1-(3-Methyl-2-butenyl)-4-[(1R)-1-phenyl-2-(3-hydroxyphenyl)ethyl]piperazine | AD-1211 | CC(=CCN1CCN(CC1)C(CC2=CC(=CC=C2)O)C3=CC=CC=C3)C |
8 | 83374-54-3 | 3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]-2-phenylethyl]phenol | Diphenpipenol | COC1=CC=CC=C1N1CCN(C(CC2=CC(O)=CC=C2)C2=CC=CC=C2)CC1 |
9 | 22312-16-9 | 2-(ethylamino)-1,2-diphenylethanone | βk-Ephenidine | CCNC(C(=O)C1=CC=CC=C1)C1=CC=CC=C1 |
10 | 27590-61-0 | 1,2-diphenyl-2-(1-pyrrolidinyl)ethanone | α-D2PV(DPPE) | O=C(C1=CC=CC=C1)C(C1=CC=CC=C1)N1CCCC1 |
11 | 1-(2H-1,3-benzodioxol-5-yl)-2-(methylamino)-2-phenylethan-1-one | CNC(C(=O)C1=CC=C2OCOC2=C1)C1=CC=CC=C1 |
||
12 | 1-(2H-1,3-benzodioxol-5-yl)-2-phenyl-2-(pyrrolidin-1-yl)ethan-1-one | MD-α-D2PV | O=C(C1=CC=C2OCOC2=C1)C(C1=CC=CC=C1)N1CCCC1 |
取代苄基哌嗪
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 21867-69-6 | 1-(4-Methoxybenzyl)piperazine | 4-MeO-BZP | COC1=CC=C(CN2CCNCC2)C=C1 |
2 | 70931-28-1 | 1-(4-Fluorobenzyl)piperazine | 4-F-BZP | FC1=CC=C(CN2CCNCC2)C=C1 |
3 | 32231-06-4 | 1-(3,4-Methylenedioxybenzyl)piperazine | MDBZP | C1CN(CCN1)CC2=CC3=C(C=C2)OCO3 |
4 | 5321-48-2 | 3-Methylbenzylpiperazine | 3-Me-BZP | CC1=CC(=CC=C1)CN2CCNCC2 |
取代苯基哌嗪
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 38212-30-5 | 1-(4-Methoxyphenyl)piperazine | 4-MeOPP | COC1=CC=C(N2CCNCC2)C=C1 |
2 | 41002-77-1 | 2,3-Dichlorophenylpiperazine | 2,3-DCPP(DCPP) | ClC1=C(Cl)C(N2CCNCC2)=CC=C1 |
3 | 1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine | 3C-PEP | ClC1=CC=CC(N2CCN(CCC3=CC=CC=C3)CC2)=C1 |
取代甲卡西酮
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 692720-34-6 | 1-(2-chlorophenyl)-2-(methylamino)propan-1-one | 2-CMC | CNC(C)C(=O)C1=CC=CC=C1Cl |
取代印满
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 24445-44-1 | N-methyl-2,3-dihydro-1H-inden-2-amine | NM-2-AI | CNC1CC2=C(C=CC=C2)C1 |
2 | 132741-82-3 | 5,6-Methylenedioxy-2-methylaminoindan | MDMAI | CNC1CC2=C(C=C3OCOC3=C2)C1 |
类 MDA
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 749191-14-8 | 1-(7-methyl-1,3-benzodioxol-5-yl)propan-2-amine | 5-Me-MDA | CC(N)CC1=CC2=C(OCO2)C(C)=C1 |
2 | 1-(2,2-dimethyl-1,3-benzodioxol-5-yl)propan-2-amine | IDA | CC(CC1=CC2=C(C=C1)OC(O2)(C)C)N |
|
3 | 152623-93-3 | 1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine | 6-APDB | CC(N)CC1=CC2=C(C=C1)CCO2 |
4 | 13396-94-6 | (±)-1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine | 5-APDI | CC(N)CC1=CC2=C(C=C1)CCC2 |
类 MDMA
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 135795-90-3 | 1-(1,3-Benzodioxol-5-yl)-N-methylbutan-2-amine | MBDB | CCC(CC1=CC=C2OCOC2=C1)NC |
2 | 1157947-89-1 | 1-(1,3-benzodioxol-5-yl)-4-methyl-2-(methylamino)pentan-1-one | PD-130868 | CNC(CC(C)C)C(=O)C1=CC=C2OCOC2=C1 |
3 | 1364933-82-3 | 2-(Ethylamino)-1-(7-methy-1,3-benzodioxol-5-yl)ethan-1-one | 5-Methylethylone | CCNC(C)C(=O)C1=CC(C)=C2OCOC2=C1 |
4 | 746541-09-3 | 1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-ylheptan-1-one | MDPV8 | CCCCCC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1 |
5 | 749145-17-3 | 1-(1,3-benzodioxol-5-yl)-4-methyl-2-pyrrolidin-1-ylpentan-1-one | MDPIHP | CC(C)CC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1 |
6 | 133787-66-3 | 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-methylpropan-2-amine | EDMA | CNC(C)CC1=CC=C2OCCOC2=C1 |
7 | 1354631-79-0 | 1-(Benzofuran-6-yl)-N-methylpropan-2-amine | 6-MAPB | CC(NC)CC1=CC(OC=C2)=C2C=C1 |
8 | 1445566-01-7 | 1-(1-Benzofuran-5-yl)-N-ethylpropan-2-amine | 5-EAPB | CC(NCC)CC1=CC(C=CO2)=C2C=C1 |
9 | 1354631-78-9 | 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine | 5-MAPDB | CC(NC)CC1=CC(CCO2)=C2C=C1 |
10 | 1354631-81-4 | 1-(2,3-dihydro-1-benzofuran-6-yl)-N-methylpropan-2-amine | 6-MAPDB | CC(CC1=CC2=C(CCO2)C=C1)NC |
xPH
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 93148-46-0 | Propan-2-yl 2-phenyl-2-piperidin-2-ylacetate | iPPH | CC(C)OC(=O)C(C1=CC=CC=C1)C1CCCCN1 |
2 | 1354631-33-6 | methyl-2-(4-fluorophenyl)-2-piperidin-2-ylacetate | 4-F-MPH | COC(=O)C(C1=CC=C(F)C=C1)C1CCCCN1 |
3 | 191790-79-1 | methyl-2-(4-methylphenyl)-2-piperidin-2-ylacetate | 4-Me-MPH | COC(=O)C(C1=CC=C(C)C=C1)C1CCCCN1 |
4 | 24558-01-8 | [(R)-phenyl-[(2R)-piperidin-2-yl]methyl]acetate | Levophacetoperane | CC(=O)O[C@H](C1=CC=CC=C1)[C@H]1CCCCN1 |
5 | 2865958-69-4 | Methyl-2-(3-bromophenyl)-2-(piperidin-2-yl)acetate | 3-Br-MPH | COC(=O)C(C1=CC=CC(Br)=C1)C1CCCCN1 |
6 | 2160555-59-7 | Ethyl2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | 4-F-EPH | CCOC(=O)C(C1=CC=C(F)C=C1)C1CCCCN1 |
7 | 231299-82-4 | Methyl(naphthalen-2-yl)(piperidin-2-yl)acetate | HDMP-28 | COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC3=CC=CC=C3C=C2 |
8 | 2170529-69-6 | Ethyl(naphthalen-2-yl)(piperidin-2-yl)acetate | HDEP-28 | CCOC(=O)C(C1CCCCN1)C2=CC3=CC=CC=C3C=C2 |
xD2PM
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 22348-34-9 | diphenyl(pyrrolidin-2-yl)methanol | D2PM | C1CC(NC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O |
2 | 119237-64-8 | 2-(Diphenylmethyl)pyrrolidine | Desoxy-D2PM | C1=CC=C(C(C2=CC=CC=C2)C2CCCN2)C=C1 |
取代甲基苯丙胺
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 341-00-4 | 2-(Diphenylmethylidene)butan-1-amine | Etifelmine | CCC(CN)=C(C1=CC=CC=C1)C1=CC=CC=C1 |
2 | 768295-94-9 | 1,1-diphenyl-2-methylaminopropane | β-Phenylmethamphetamine | CNC(C)C(C1=CC=CC=C1)C1=CC=CC=C1 |
3 | 21906-17-2 | 3-Phenylbutan-2-amine | β-methylamphetamine | CNC(C)C(C)C1=CC=CC=C1 |
xPM
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 1097796-78-5 | 3-methyl-2-(3-chlorophenyl)morpholine | 3-CPM | CC1NCCOC1C1=CC(Cl)=CC=C1 |
2 | 2-(1,3-benzodioxol-5-yl)-3-methylmorpholine | MDPM | CC1NCCOC1C1=CC=C2OCOC2=C1 |
|
3 | 1350769-57-1 | 3-methyl-2-naphthalen-2-ylmorpholine | CC1NCCOC1C1=CC=C2C=CC=CC2=C1 |
|
4 | 1094649-71-4 | 3-methyl-2-(4-methylphenyl)morpholine | 4-MPM | CC1=CC=C(C2OCCNC2C)C=C1 |
5 | 1350768-49-8 | 2-(3-methoxyphenyl)-3-methylmorpholine | 3-MeOPM | COC1=CC=CC(C2OCCNC2C)=C1 |
类甲喹酮
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 4260-20-2 | 3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one | MBQ | CC1=NC2=C(C=CC=C2)C(=O)N1C1=C(Br)C=CC=C1 |
2 | 3-(2-chlorophenyl)-2-phenylquinazolin-4(3H)-one | PPQ | O=C1C2=CC=CC=C2N=C(C2=CC=CC=C2)N1C1=CC=CC=C1Cl |
|
3 | 6-Amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4-one | CC1=CC=CC=C1N1C(CF)=NC2=CC=CC=C2C1=O |
||
4 | 340-52-3 | 2-methyl-3-(2-methoxy-4-nitrophenyl)-4(3H)-quinazolinone | Nitromethaqualone | COC1=CC([N+](=O)[O-])=CC=C1N1C(C)=NC2=CC=CC=C2C1=O |
5 | 4260-28-0 | 3-(2-methoxyphenyl)-2-methylquinazolin-4(3H)-one | OC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O |
|
6 | 3244-75-5 | 3-(2,4-dimethylphenyl)-2-methylquinazolin-4(3H)-one | MMQ | CC1=CC=C(N2C(C)=NC3=CC=CC=C3C2=O)C(C)=C1 |
7 | 36518-02-2 | 3-(2,3-dihydroxypropyl)-2-methyl-quinazolin-4-one | Diproqualone | CC1=NC2=CC=CC=C2C(=O)N1CC(O)CO |
BZDs
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 2243815-18-9 | 1-methyl-8-nitro-6-(2-fluorophenyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | FNTZ | CC1=NN=C2CN=C(C3=C(F)C=CC=C3)C3=CC([N+](=O)[O-])=CC=C3N12 |
2 | 39243-02-2 | 8-bromo-1-methyl-6-pyridin-2-yl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | SH-I-04 | CC1=NN=C2CN=C(C3=CC=CC=N3)C3=CC(Br)=CC=C3N12 |
3 | 2886-65-9 | 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one | Norfludiazepam | O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1 |
类 BZDs
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 31352-82-6 | 4-(2-fluorophenyl)-1,3,8-trimethyl-6H-pyrazolo[3,4-e][1,4]diazepin-7-one | Zolazepam | C1=NN(C)C2=C1C(C1=CC=CC=C1F)=NCC(=O)N2C |
取代依托咪酯
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | CCOC(=O)C1=CN=CN1C(C)C1=CC=C(F)C=C1 |
|||
2 | 801156-47-8 | tert-butyl 3-(1-phenylethyl)imidazole-4-carboxylate | tert-Butomidate | CC(C1=CC=CC=C1)N1C=NC=C1C(=O)OC(C)(C)C |
类莫达非尼
序号 | CAS号 | 英文名 | 备注 | 结构式 |
1 | 1879038-73-9 | (S)-5-(benzhydrylsulfinylmethyl)-1,3-thiazole | CE-123 | O=[S@@](CC1=CN=CS1)C(C1=CC=CC=C1)C1=CC=CC=C1 |
2 | 2621388-55-2 | 5-(3-bromophenyl)-phenylmethyl sulfinylmethyl-1,3-thiazole | CE-158 | O=S(CC1=CN=CS1)C(C1=CC=CC=C1)C1=CC(Br)=CC=C1 |
3 | 90280-13-0 | (2-Amino-2-oxoethyl)[bis(4-fluorophenyl)methyl]sulfoniumolate | Flmodafinil | NC(=O)CS(=O)C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1 |
右美沙芬的结构改造及其受体活性变化分析:从多靶点作用到1-(2-phenylethyl)-4-[3-(trifluoromethyl)phenyl]piperidine的药理探索
截至2025.07.01,中国全部的管制药品目录